Immunological studies in angioimmunoblastic lymphadenopathy

Area of Science:

• Immunology
• Hematology
• Cellular Biology

Background:

• Angioimmunoblastic lymphadenopathy (AIL) is a complex T-cell-mediated lymphoproliferative disorder.
• Patients often present with constitutional symptoms, lymphadenopathy, and immune dysregulation.

Observation:

• Two female patients with AIL exhibited fever, lymphadenopathy, hepatosplenomegaly, rash, and hypersensitivity reactions.
• During active disease, cellular immunity was suppressed, with abnormal T-cell blastogenesis.
• A non-dialyzable plasma factor inhibiting normal lymphocyte blastogenesis was identified in one patient and during relapse in the second.

Findings:

• Removal of the inhibitory plasma factor enhanced AIL lymphocyte activation.
• The second patient showed clinical remission and restored cellular immunity parameters following steroid and levamisole therapy.
• Evidence suggests defective B-cell regulation with impaired suppressor function, leading to immunoglobulin overproduction in AIL.

Implications:

• The findings suggest a role for inhibitory plasma factors in AIL pathogenesis.
• Therapeutic strategies targeting immune dysregulation, such as steroids and levamisole, may be beneficial.
• Further research into B-cell regulation and suppressor cell function in AIL is warranted.